Men and women now have their own blue and pink pills
WASHINGTON - The FDA approved the first-of-its kind drug for women that rivals Viagra Tuesday.
But, the safety restrictions associated with the new drug Addyi might keep it from being used as widespread as the "little blue pill." The Associated Press reported, the new drug's label will carry a bold warning that combining it with alcohol can cause dangerously low blood pressure and fainting. Those problems can also occur if the drug is taken alongside certain common medications, including drugs used to treat yeast infections.
The FDA twice rejected the drug over concerns about its side effects and what has been described as lackluster benefits.
Viagra, the male counterpart, has generated billions of dollars.
Follow the publisher of this post on Twitter: @treyschmaltz
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
LSU begins digitizing century-old editions of longtime campus newspaper
Hundreds of volunteers pick up litter around the capital city
New entertainment venue set to open at Mall of Louisiana in 2019
Cheeky Capitol parking lot security system strikes again
Denham Springs adds second resource officer to watch its schools